Home

PB Ratio of Astrazeneca Pharma India Ltd

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

PB Ratio

29.3

Last updated on: Sep 08, 2025

Key Highlights

  • The latest PB Ratio of Astrazeneca Pharma India Ltd is 29.3.
  • The PB ratio of the Astrazeneca Pharma India Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
  • The P/B Ratio of Astrazeneca Pharma India Ltd changed from 16.4 on March 2020 to 27.9 on March 2025 . This represents a CAGR of 9.26% over 6 years.

Historical P/B Ratio of Astrazeneca Pharma India Ltd

No data available

Company Fundamentals for Astrazeneca Pharma India Ltd

Market Cap

22,584 Cr

EPS

84.6

P/E Ratio (TTM)

106.8

P/B Ratio (TTM)

29.3

Day’s High

9116.3

Day’s Low

8927.5

DTE

0.0

ROE

22.7

52 Week High

10653.05

52 Week Low

6222.35

ROCE

31.2

Market Price of Astrazeneca Pharma India Ltd

1M

1Y

3Y

5Y

Monitoring Astrazeneca Pharma India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
08 Sep 20259033.8
05 Sep 20259088.15
04 Sep 20259089.7
03 Sep 20259084.3
02 Sep 20258937.85
01 Sep 20258751.75
29 Aug 20258469.45
28 Aug 20258322.7
26 Aug 20258014.9
25 Aug 20258297.1

SWOT Analysis

Strength

0

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Astrazeneca Pharma India Ltd

Asset Value vs Market Value of Astrazeneca Pharma India Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PB Ratio of Astrazeneca Pharma India Ltd Explained

22584

Market cap

308

Book Value per Share

29.3X

PB Ratio

Historical Market Cap of Astrazeneca Pharma India Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Astrazeneca Pharma India Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Astrazeneca Pharma India Ltd News Hub

AstraZeneca slumps on recording dismal Q1 performance

Revenue from operations jumped 31.15% year on year (YoY) to Rs 387.52 crore in the quarter ended 30

Read more

08 Aug 24

Astrazeneca Pharma India reports standalone net loss of Rs 11.79 crore in the June 2024 quarter

Net loss of Astrazeneca Pharma India reported to Rs 11.79 crore in the quarter ended June 2024 as ag

Read more

08 Aug 24

Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions

Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed by IMFINZI

Read more

24 Sept 24

Astrazeneca Pharma India Ltd leads gainers in 'A' group

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and National Alumini

Read more

24 Sept 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Astrazeneca Pharma India Ltd

What is the PB ratio of Astrazeneca Pharma India Ltd?

The current PB ratio of Astrazeneca Pharma India Ltd is 29.32. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Astrazeneca Pharma India Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Astrazeneca Pharma India Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Astrazeneca Pharma India Ltd calculated?

The PB ratio of Astrazeneca Pharma India Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Astrazeneca Pharma India Ltd?

A high PB ratio suggests that Astrazeneca Pharma India Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Astrazeneca Pharma India Ltd?

A low PB ratio of Astrazeneca Pharma India Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Astrazeneca Pharma India Ltd PB Ratio change over time?

Yes, the PB ratio of Astrazeneca Pharma India Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions